MH
MOHAMMAD HASANAIN
Sylvester Comprehensive Cancer Center, University of Miami Health Systems, Columbia University Irving Medical Center, CSIR-Central Drug Research Institute
0000-0001-5207-101X
Employment
-
Sylvester Comprehensive Cancer Center, University of Miami Health Systems Associate Scientist2022 - Present
-
Columbia University Irving Medical Center Post-Doctoral Scientist2020 - 2022
Education
-
CSIR-Central Drug Research Institute2012 - 2019
Projects & Funding
Projects & funding information is unavailable.
Publications (30)
- LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL Save
- Integrative multi-omics networks identify PKCδ and DNA-PK as master kinases of glioblastoma subtypes and guide targeted cancer therapy Save
- The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen Save
- Inhibition of p21 activates Akt kinase to trigger ROS-induced autophagy and impacts on tumor growth rate Save
- DEVELOPMENT OF THERAPEUTIC STRATEGIES BY PATHWAY-BASED MULTI-OMICS APPROACH AND MASTER KINASE ANALYSIS IN GLIOBLASTOMA MULTIFORME Save
- EGFR AND AXL RECEPTOR TYROSINE KINASES DRIVE ONCOGENESIS BY LZTR1 MUTATION Save
- PATHWAY-BASED STRATIFICATION OF GLIOBLASTOMA BY MULTI-OMICS INFORMS SUBTYPE-SPECIFIC MASTER KINASES-PHOSPHOSITE SUBSTRATES Save
- Facile synthesis of rapamycin-peptide conjugates as mTOR and Akt inhibitors Save
- Gedunin isolated from the mangrove plant Xylocarpus granatum exerts its anti-proliferative activity in ovarian cancer cells through G2/M-phase arrest and oxidative stress-mediated intrinsic apoptosis Save
- Microtubule disrupting agent-mediated inhibition of cancer cell growth is associated with blockade of autophagic flux and simultaneous induction of apoptosis Save